Track the evolution of major financial and economic events
A Los Angeles jury found Meta and YouTube liable for making their platforms addictive and harming the mental health of young users. A New Mexico jury fined Meta $375 million for failing to protect children and disclose risks on its platforms. TikTok and Snap settled their cases before trial, leaving Meta and YouTube to face damages alone in the Los Angeles case.
Qatar's shutdown of the world's largest LNG facility has disrupted global helium supply, threatening critical sectors such as semiconductor manufacturing, medical applications, and national defense technology. This disruption is directly linked to the ongoing conflict in the Middle East and its impact on energy facilities. Experts have warned that the petrochemical supply shock is affecting a range of industries in Asia, resulting in a 29% increase in costs of raw materials like PTA and Caprolactam. This impact also extends to textile and apparel production in India.
On April 4, FCA chief Nikhil Rathi warned that pursuing court cases could disqualify consumers from a projected £9 billion car finance redress scheme. The regulator is gearing up for a standoff with claims management companies and law firms pushing for litigation. The issue relates to historical discretionary commission arrangements within the car finance sector.
In April 2026, global data centers faced threats from drones, prompting a shift towards AI-powered physical defenses. Major companies like Microsoft, Google, and Oracle heavily invested in protecting their infrastructure, while governments responded swiftly by approving laser systems to combat drones. Meanwhile, Ukraine showcased advancements in developing sophisticated unmanned platforms, reflecting a global race to secure technology against rising threats.
On April 3, Trump proposed a historic $1.5 trillion surge in defense spending, the largest since World War II. Economist Steve Hanke described the move as a massive militarization that lacks a clear funding plan.
On April 2, 2025, President Trump introduced higher 'reciprocal' tariff rates for U.S. importers. The following day, companies and countries began altering their supply chains to reduce their trade tax bills. Entities are also striking deals with the White House to mitigate the impact of these tariffs.
On April 3, Elon Musk announced the end of custom orders for the Model S sedan and Model X SUV, with only a few hundred unsold vehicles remaining in inventory. Tesla is now fully pivoting towards the 'Cybercab' autonomous vehicle. On April 6, a mother filed a wrongful death lawsuit against Tesla after her 14-year-old son and his father died in a Model 3 crash, alleging that the car's features did not function as marketed, leading to the accident. On April 7, Tesla's vehicle registrations in Germany quadrupled in March compared to the previous year.
On March 31, MSCI announced that it will reclassify Greece's indexes from Emerging Market to Developed Market status in a single step in May 2027. This decision follows consultations with global institutional investors who supported Greece's progress in market infrastructure. The implementation date of May 2027 was chosen over August 2026 based on investor feedback.
Caris Life Sciences announced positive results for its multi-cancer detection study. On March 31, the company finalized the Achieve 1 study, validating the accuracy of its Caris Detect early detection test. The results demonstrated the superiority of Whole Genome Sequencing (WGS) over methylation-based approaches in sensitivity and specificity. This milestone is a key step toward the future launch of the Caris Detect™ test.
On March 31, the Global X Copper Miners ETF (COPX) surged by 7.92% to a price of 76.35. Reports include analyses on the demand for critical metals and the impact of inflation on markets in early 2025. The coverage also featured technical analysis from Ira Epstein regarding gold and other metals.
Carvana shares surged nearly 8% after Jefferies reiterated its bullish stance on the stock. Jefferies maintained a 'Buy' rating with a $485 price target, implying a potential 67% upside. The optimism is driven by stronger-than-expected retail unit growth and improving pricing trends in Q1.
Constellation Energy shares dropped by 8.3% following an investor update on March 31. The company forecasted 2026 adjusted earnings below analyst expectations. Additionally, no new data center deals were announced during the update, disappointing market expectations.
On March 31, Korean Air implemented emergency measures to cope with soaring fuel costs. This price surge is linked to the economic impact of the Iran conflict.
Walker & Dunlop is facing a fraud investigation following a massive earnings miss, with adjusted earnings per share for Q4 2025 nearly 81% below consensus estimates. On March 31, the Schall Law Firm initiated an investigation into potential securities law violations by the company. The company's stock fell by more than 19.4% on the day of the announcement.
On March 31, IonQ announced its acquisition of SkyWater Technology for $1.8 billion to gain control over its quantum hardware supply chain. The deal aims to improve chip design and manufacturing to accelerate the development of commercially viable, fault-tolerant quantum computing. However, the acquisition raises concerns regarding integration complexity and capital needs, given IonQ's history of unprofitability.
On March 31, the U.S. District Court for the District of Nevada upheld the federal approval for Ioneer Ltd's Rhyolite Ridge lithium project, which is listed on both NASDAQ and ASX. This decision was made in the case Center for Biological Diversity v. Stone-Manning.
On March 30, BullFrog AI signed a commercial agreement with a top 5 global pharmaceutical company by revenue. The agreement utilizes the proprietary bfLEAP® platform to identify and prioritize therapeutic targets for Major Depressive Disorder (MDD). The MDD market was valued at over $8 billion in 2025 and is expected to exceed $11 billion by 2032.
On March 30, the Court of King's Bench of Alberta approved the appointment of Breakpoint Advisory Partners LLC as Chief Restructuring Officer (CRO) for Canacol Energy. The restructuring proceedings are being conducted under the Companies' Creditors Arrangement Act (CCAA) in Canada. The company's shares are traded under the tickers CNNEF on the OTCQX and CNEC on the Bolsa de Valores de Colombia.
4DMedical received CE Mark certification for its CT:VQ™ technology for commercial use in the European Union. The company secured A$83 million in private placement funding to support growth initiatives. The new funding will be used to support commercial expansion in Europe and software development.
Medicus Pharma reported an 80% overall response rate (ORR) in Phase 2 data for SkinJect. Dr. Babar Rao, a key opinion leader, validated that the outcomes are clinically meaningful for treating non-melanoma skin cancer. The treatment could potentially allow the majority of lesions to avoid immediate surgery.
Sable Offshore Corp. officially commenced oil sales from the Santa Ynez Pipeline System on March 30. Based in Houston, this move marks a transition to the revenue-generation phase from its assets.
On March 30, Sintana Energy announced a 57% increase in contingent resources at the Mopane oil complex off the coast of Namibia. Gross 3C contingent resources were raised from 875 million barrels to 1.38 billion barrels. Sintana's net interest in the project has risen to approximately 67 million barrels of oil equivalent.
On March 29, Lockheed Martin announced a new framework agreement to quadruple the production of Precision Strike Missiles (PrSM). This production expansion builds on an existing $4.94 billion contract. Additionally, its subsidiary Sikorsky successfully tested and delivered an autonomous Black Hawk helicopter to the U.S. Army.
The HI-PEITHO trial results demonstrated that the EKOS system combined with anticoagulation is superior to anticoagulation alone for treating acute pulmonary embolism. The study showed a statistically significant reduction in clinical event rates among intermediate-risk patients. Findings were published in The New England Journal of Medicine and presented at the ACC.26 conference.
